Pharmacological OGG1 inhibition decreases murine allergic airway inflammation is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5P01AI062885-12
Epithelial innate signaling in airway inflammation and remodeling
European Commission
Grant: 957495
Development of small molecule OGG1 Inhibitor and proof of concept in bleomycin-induced disease model of Inflammation and pulmonary Fibrosis
FWCI
2.42
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals